Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.65 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | GRM1 | Q13255 | 6/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | PDE4A | P27815 | 3/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.32 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.32 |
| ▸ | CTSV | O60911 | 1/20 | 0.31 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29353750 | 1.00 | ATM (0.65) | ATMCYP19A1GRM1POLBPDE4A | |
| SCHEMBL23494105 | 0.91 | ATM (0.53) | ATMCYP19A1GRM1 | |
| SCHEMBL23494271 | 0.89 | ATM (0.53) | ATMCYP19A1GRM1 | |
| Methacrylic Acid SCHEMBL9864431 | 0.89 | ATM (0.57) | ATMCYP19A1GRM1POLBPDE4A | |
| SCHEMBL23494082 | 0.89 | ATM (0.51) | ATMCYP19A1GRM1POLB | |
| SCHEMBL23493883 | 0.87 | ATM (0.49) | ATMCYP19A1POLB | |
| SCHEMBL1591877 | 0.86 | ATM (0.47) | ATMCYP19A1 | |
| SCHEMBL1945670 | 0.85 | ATM (0.50) | ATMCYP19A1GRM1POLBPDE4A | |
| SCHEMBL4858290 | 0.81 | ATM (0.65) | ATMCYP19A1GRM1POLBPDE4A | |
| SCHEMBL17915916 | 0.79 | ATM (0.47) | ATMCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240076428-A1 | AQUEOUS POLYMER DISPERSION OF VOIDED POLYMER PARTICLES | BASF SE (DE) | 2024-03-07 | — | — | US | claimed |
| EP-4314100-A1 | AQUEOUS POLYMER DISPERSION OF VOIDED POLYMER PARTICLES | BASF SE (DE) | 2024-02-07 | — | — | EP | claimed |
| CN-117136203-A | Aqueous polymer dispersions of hollow polymer particles | 巴斯夫欧洲公司 | 2023-11-28 | — | — | CN | claimed |
| WO-2022207783-A1 | AQUEOUS POLYMER DISPERSION OF VOIDED POLYMER PARTICLES | BASF SE (DE) | 2022-10-06 | — | — | WO | claimed |
| US-9611402-B2 | Hot melt compositions with improved etch resistance | ROHM AND HAAS ELECTRONICS MATERIALS LLC (US) | 2017-04-04 | — | — | US | claimed |
| US-8299191-B2 | Shape memory polymers and process for preparing | GEORGIA TECH RESEARCH CORP. (US) | 2012-10-30 | — | — | US | claimed |
| EP-2491082-A1 | SHAPE MEMORY POLYMERS AND PROCESS FOR PREPARING | Georgia Tech Research Corporation (US) | 2012-08-29 | — | — | EP | claimed |
| WO-2011049879-A1 | SHAPE MEMORY POLYMERS AND PROCESS FOR PREPARING | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-04-28 | — | — | WO | claimed |
| US-20110092652-A1 | SHAPE MEMORY POLYMERS AND PROCESS FOR PREPARING | GEORGIA TECH RESEARCH CORPORATION | 2011-04-21 | — | — | US | claimed |
| US-12570787-B2 | Curable compositions and articles prepared therefrom | TRANSITIONS OPTICAL, LTD. (IE) | 2026-03-10 | — | — | US | disclosed |
| US-12503543-B2 | Curable photochromic polycarbodiimide compositions | TRANSITIONS OPTICAL, LTD. (IE) | 2025-12-23 | — | — | US | disclosed |
| EP-4562458-A1 | CURABLE PHOTOCHROMIC COMPOSITIONS INCLUDING HYDRAZIDE AND CARBONYL FUNCTIONAL COMPONENTS | Transitions Optical, Ltd. (IE) | 2025-06-04 | — | — | EP | disclosed |
| CN-119895299-A | Curable photochromic compositions comprising a hydrazide and a carbonyl functional component | 全视线光学有限公司 | 2025-04-25 | — | — | CN | disclosed |
| EP-4526365-A1 | ACRYLATE-EPOXY RESIN COMPOSITIONS | Lyondellbasell Composites LLC (US) | 2025-03-26 | — | — | EP | disclosed |
| US-6677419-B1 | REACTING STOICHIOMETRIC EXCESS OF UNSATURATED ALICYCLIC MONOMER WITH ANOTHER UNSATURATED MONOMER, HAVING LESS THAN TWO ELECTRON-WITHDRAWING GROUPS APPENDED TO UNSATURATION, IN PRESENCE OF FREE RADICAL INITIATOR | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2004-01-13 | — | — | US | disclosed |
| US-20020168583-A1 | Chemical amplifying type positive resist composition | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2002-11-14 | — | — | US | disclosed |
| US-20020155378-A1 | Chemical amplifying type positive resist compositions | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2002-10-24 | — | — | US | disclosed |
| US-4119640-A | ACRYLIC OR METHACRYLIC ACID, DIEPOXIDES, INKS, HEAT OR RADIATION CURABLE COATINGS | UNION CARBIDE CORPORATION (US) | 1978-10-10 | — | — | US | disclosed |
| US-4100046-A | Radiation polymerizable cycloalkenyl derivatives of acrylated epoxidized fatty oils or fatty acids | UNION CARBIDE CORPORATION (US) | 1978-07-11 | — | — | US | disclosed |
| US-3940360-A | ACRYLIC POLYMER | UNION CARBIDE CORPORATION (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570787-B2 | Curable compositions and articles prepared therefrom | EHMT2, EHMT1, BHMT2 | ATM 105/4885CYP19A1 1999/4885GRM1 405/4885 |
| US-20020168583-A1 | Chemical amplifying type positive resist composition | POLR1A, POLL, ASIC1 | ATM 3070/4885CYP19A1 4301/4885GRM1 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.